Pfizer (NYSE:PFE) Updates FY 2025 Earnings Guidance

Pfizer (NYSE:PFE – Get Free Report) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided EPS guidance of 2.800-3.000 for the period, compared to the consensus EPS estimate of 2.930. The company issued revenue guidance of $61.0 billion-$64.0 billion, compared to the consensus revenue estimate of $63.0 billion. Pfizer […]

Leave a Reply

Your email address will not be published.

Previous post Coca-Cola (NYSE:KO) Shares Up 0.4% – Should You Buy?
Next post NVIDIA (NASDAQ:NVDA) Trading 4% Higher – Still a Buy?